Five-Year Cost-effectiveness of Intravitreous Ranibizumab Therapy vs Panretinal Photocoagulation for Treating Proliferative Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial

David W. Hutton, Joshua D. Stein, Adam R. Glassman, Neil M. Bressler, Lee M. Jampol, Jennifer K. Sun

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Five-Year Cost-effectiveness of Intravitreous Ranibizumab Therapy vs Panretinal Photocoagulation for Treating Proliferative Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences